These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32674494)

  • 1. P2 Purinergic Signaling in the Distal Lung in Health and Disease.
    Wirsching E; Fauler M; Fois G; Frick M
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis.
    Riteau N; Gasse P; Fauconnier L; Gombault A; Couegnat M; Fick L; Kanellopoulos J; Quesniaux VF; Marchand-Adam S; Crestani B; Ryffel B; Couillin I
    Am J Respir Crit Care Med; 2010 Sep; 182(6):774-83. PubMed ID: 20522787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular adenosine 5'-triphosphate in pulmonary disorders.
    Pelleg A
    Biochem Pharmacol; 2021 May; 187():114319. PubMed ID: 33161021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purinergic P2X7 receptor regulates lung surfactant secretion in a paracrine manner.
    Mishra A; Chintagari NR; Guo Y; Weng T; Su L; Liu L
    J Cell Sci; 2011 Feb; 124(Pt 4):657-68. PubMed ID: 21266468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alveolar lipids in pulmonary disease. A review.
    Agudelo CW; Samaha G; Garcia-Arcos I
    Lipids Health Dis; 2020 Jun; 19(1):122. PubMed ID: 32493486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary surfactant protein SP-B promotes exocytosis of lamellar bodies in alveolar type II cells.
    Martínez-Calle M; Olmeda B; Dietl P; Frick M; Pérez-Gil J
    FASEB J; 2018 Aug; 32(8):4600-4611. PubMed ID: 29543530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive Extracellular ATP Desensitizes P2Y2 and P2X4 ATP Receptors Provoking Surfactant Impairment Ending in Ventilation-Induced Lung Injury.
    Hasan D; Satalin J; van der Zee P; Kollisch-Singule M; Blankman P; Shono A; Somhorst P; den Uil C; Meeder H; Kotani T; Nieman GF
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis.
    Lutz D; Gazdhar A; Lopez-Rodriguez E; Ruppert C; Mahavadi P; Günther A; Klepetko W; Bates JH; Smith B; Geiser T; Ochs M; Knudsen L
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):232-43. PubMed ID: 25033427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights of P2X7 receptor signaling pathway in alveolar functions.
    Mishra A
    J Biomed Sci; 2013 May; 20(1):26. PubMed ID: 23634990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis.
    Song L; Li K; Chen H; Xie L
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):30-42. PubMed ID: 38579159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis.
    Ohta H; Chiba S; Ebina M; Furuse M; Nukiwa T
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L193-205. PubMed ID: 22003091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2 receptor-mediated signaling in the physiological and pathological brain: From development to aging and disease.
    Mut-Arbona P; Sperlágh B
    Neuropharmacology; 2023 Aug; 233():109541. PubMed ID: 37062423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic signaling in the pulmonary neuroepithelial body microenvironment unraveled by live cell imaging.
    De Proost I; Pintelon I; Wilkinson WJ; Goethals S; Brouns I; Van Nassauw L; Riccardi D; Timmermans JP; Kemp PJ; Adriaensen D
    FASEB J; 2009 Apr; 23(4):1153-60. PubMed ID: 19050048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.
    Mulugeta S; Nureki S; Beers MF
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L507-25. PubMed ID: 26186947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
    Higgins G; Buchanan P; Perriere M; Al-Alawi M; Costello RW; Verriere V; McNally P; Harvey BJ; Urbach V
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):178-90. PubMed ID: 24588705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orphan G protein-coupled receptor GPR116 regulates pulmonary surfactant pool size.
    Bridges JP; Ludwig MG; Mueller M; Kinzel B; Sato A; Xu Y; Whitsett JA; Ikegami M
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):348-57. PubMed ID: 23590306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.
    Neary JT; Kang Y
    J Neurosci Res; 2006 Aug; 84(3):515-24. PubMed ID: 16810687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.